Civic Signal GUEST
ROWS
API PATHS
Docs Sign in
Browsing as a guest. A free key raises the rate limit.

Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B)

Contracts Finder notice active GET /api/v1/contracts/114920
£71,550
value
GBP
1 Jan 2025
awarded
1
suppliers named

Who

Buyer Norfolk and Norwich University Hospitals NHS Foundation Trust — not a council we hold
Supplier Octapharma Limited

What

Call off contract/order from the NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A & B. Offer reference number: CM/PHS/22/5661 Specifically for products: Fibryga Octaplas

Dates and source

Runs 1 Jan 2025 to 30 Apr 2027
OCID ocds-b5fd17-1fa41b41-b7a5-488b-a97d-be850460433e
Notice Read it on Contracts Finder

Figures are as published An award value in OCDS may be a framework ceiling rather than a sum anyone expects to spend, so a large figure here is not evidence of a large purchase.